Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Fate Therapeutics (FATE) Profit After Tax (2016 - 2025)

Historic Profit After Tax for Fate Therapeutics (FATE) over the last 14 years, with Q3 2025 value amounting to -$32.2 million.

  • Fate Therapeutics' Profit After Tax rose 3235.87% to -$32.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$156.1 million, marking a year-over-year increase of 1242.04%. This contributed to the annual value of -$186.3 million for FY2024, which is 1574.24% down from last year.
  • Fate Therapeutics' Profit After Tax amounted to -$32.2 million in Q3 2025, which was up 3235.87% from -$34.1 million recorded in Q2 2025.
  • Over the past 5 years, Fate Therapeutics' Profit After Tax peaked at -$18.9 million during Q1 2023, and registered a low of -$83.6 million during Q3 2022.
  • In the last 5 years, Fate Therapeutics' Profit After Tax had a median value of -$47.7 million in 2024 and averaged -$49.7 million.
  • In the last 5 years, Fate Therapeutics' Profit After Tax surged by 7126.18% in 2023 and then tumbled by 15424.5% in 2024.
  • Quarter analysis of 5 years shows Fate Therapeutics' Profit After Tax stood at -$68.6 million in 2021, then increased by 17.86% to -$56.4 million in 2022, then grew by 21.72% to -$44.1 million in 2023, then fell by 18.2% to -$52.2 million in 2024, then soared by 38.16% to -$32.2 million in 2025.
  • Its Profit After Tax was -$32.2 million in Q3 2025, compared to -$34.1 million in Q2 2025 and -$37.6 million in Q1 2025.